C the Signs has announced an $8 million investment from Khosla Ventures to expand their AI-based cancer risk assessment platform from the U.K. to the U.S. This platform helps identify patients at risk of cancer earlier by analyzing data from electronic health records.
Company Information
Company
C the Signs
Location
London, England, United Kingdom
About
C the Signs is a cancer prediction system that can identify patients at risk of cancer at the earliest and most curable stage of the disease.
In under 30 seconds, C the Signs can rapidly identify which cancers a patient is at risk of and recommend the most appropriate test or specialist to diagnose their cancer.
Using the latest technology, research and evidence, C the Signs enables healthcare providers to give their patients the best chance of surviving cancer.
Fundz sees it the moment C the Signs ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
LondonBiotechnologyHealth CareArtificial IntelligenceMedicalMachine LearningHealth Diagnostics